Ranbaxy Rank

Rediff.com » News » Ranbaxy Rank

News for Ranbaxy Rank

Business

Lessons from the Fortis/Raymond family feuds

'Nothing in this world is permanent. So also in business.''And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.......

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......

With $22.7 billion in his kitty, Mukesh Ambani is India's richest

The combined networth of India's 100 wealthiest is $381 billion (nearly Rs 25.5 lakh crore), a rise of 10 per cent from $ 345 billion in 2015 Photograph: Courtesy, Reliance Industrialist Mukesh......

What is India waiting for? Perhaps big bang M&As

After hitting a three-year low, deal values have picked up once again but only robust initiatives to improve the business environment can ensure a sustained surge, notes Kanika Datta. If the pace......

Markets rebound; Sensex, Nifty make handsome gains

Markets ended the session on a higher note after they gained ground in the last half an hour led by a rally in defensive sectors such as FMCG and Healthcare. Positive cues from Asian peers also......

Rediff News

Ranbaxy Rank

News for Ranbaxy Rank

Lessons from the Fortis/Raymond family feuds

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

With $22.7 billion in his kitty, Mukesh Ambani is India's richest

What is India waiting for? Perhaps big bang M&As

Markets rebound; Sensex, Nifty make handsome gains

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS